Overview
Portfolio
More
Jlkjtz
Portfolio
11+
Employees
N/A
Founded
N/A
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedFund details
Funds
省级创业(风险)投资基金
Sources
Jlkjtz
Portfolio
11+
Employees
N/A
Founded
N/A
AUM
N/A
Funds
省级创业(风险)投资基金
Showing 11 of 11 matched portfolio companies
AgiBot develops and manufactures humanoid robots and embodied intelligence systems designed for various applications, including interactive services and flexible manufacturing. Their technology enhances productivity by automating tasks in diverse environments, addressing labor shortages and operational inefficiencies.
Ba.co designs and fabricates custom pipe systems and related components for the milling and food‑processing industries, offering a range of stainless‑steel and carbon‑steel parts in various thicknesses. Their in‑house production ensures high‑quality, fully assembled solutions, while an online quotation tool provides fast, streamlined pricing for equipment manufacturers, plant engineers, and maintenance teams.
Com is a platform associated with Student Artificial Intelligence Technologies Inc., operating under the sai.com.ai domain. Specific details about its product or service offering are not provided in the available content.
Gen+ is a digital platform that provides leadership and meta-skills education for learners aged 9-14 and their teachers, utilizing a blended learning approach that combines online and in-person instruction. The program addresses the lack of standardized skills development in schools by equipping students with essential, transferable skills necessary for success in learning, work, and life.
Funding: $100.7K
Rough estimate of the amount of funding raised
Funding: $100.7K
Rough estimate of the amount of funding raised
The startup develops targeted therapies for cancer treatment through drug discovery focused on tumor immunology. By enhancing the immune response against tumors, the company aims to improve the quality of life for cancer patients.
Funding: $20.0M
Rough estimate of the amount of funding raised
Funding: $20.0M
Rough estimate of the amount of funding raised
Jia provides a unified financial platform for small and medium‑size businesses in emerging markets, offering invoice, inventory, and supply‑chain financing with disbursements in under 24 hours and fees of 1‑5 %. The solution includes a no‑fee business account that earns interest on idle balances and real‑time cash‑flow tracking, all integrated via API/ERP for seamless management of capital and payments.
Funding: $1.0M
Rough estimate of the amount of funding raised
Funding: $1.0M
Rough estimate of the amount of funding raised
The startup operates a molecular imaging platform that utilizes non-invasive radiopharmaceutical imaging technology to detect early-stage colorectal, esophageal, and lung adenocarcinoma. This technology enables healthcare providers to make precise diagnoses and tailor cancer treatment plans, improving patient outcomes and care efficiency.
10+
200+Approximate amount of employees
Funding: $2.5M
Rough estimate of the amount of funding raised
Funding: $2.5M
Rough estimate of the amount of funding raised
SyncData.ai offers an AI‑driven platform that automates the assessment, implementation, and ongoing monitoring of compliance frameworks across financial crime, cybersecurity, and industry standards such as AML, KYC, ISO, NIST, and DORA. The service identifies gaps, generates actionable remediation plans, and produces ready‑to‑use compliance documentation within minutes, reducing manual effort and accelerating audit readiness for financial institutions, fintechs, and other regulated enterprises.
Funding: $5.5M
Rough estimate of the amount of funding raised
Funding: $5.5M
Rough estimate of the amount of funding raised
The startup develops therapies that harness microorganisms sourced from animals, the environment, and humans to create targeted treatments for cancer. By focusing on these unique biological agents, the company provides healthcare providers with new drug options to improve patient outcomes in oncology.
Yocredito is a credit card platform in Latin America that enables users to leverage the value of their physical assets as collateral for credit. This approach addresses the lack of accessible credit options for individuals and businesses by transforming tangible assets into financial resources.
The startup develops TCR gene therapy solutions that provide personalized immunotherapy for cancer patients by engineering T-cell receptors to target specific tumor antigens. This approach enhances treatment efficacy and minimizes side effects compared to traditional therapies.